1. Home
  2. |Insights
  3. |Limits On Bid Protest Review Reinforced

Limits On Bid Protest Review Reinforced

Client Alert | less than 1 min read | 12.08.09

In Alabama Aircraft Indus., Inc.--Birmingham v. U.S. (Nov. 17, 2009), the Federal Circuit reversed the lower court for rewriting the RFP and then finding that the agency had not conducted a reasonable price realism analysis, when its review should have been limited to whether the agency's evaluation was consistent with the criteria as set forth in the RFP. The appeals court noted that this was not a case in which the agency had failed to consider an important aspect of the situation, but, rather, had considered it in a reasonable way different from that articulated by the lower court.

Insights

Client Alert | 3 min read | 11.17.26

CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs

On November 6, 2026, the Centers for Medicare and Medicaid Services (CMS) published its final 2027 Medicare Hospital Outpatient Perspective Payment System (OPPS) rule. The rule will reduce reimbursement for 340B drugs from average sales price (ASP) plus 6% (what Medicare generally pays for Part B outpatient drugs administered by providers) to ASP minus 28%, a 32% reduction. CMS originally proposed reducing reimbursement to ASP minus 33.4%. CMS indicated that this change will better align Medicare reimbursement with hospitals’ costs of acquiring 340B drugs.  ...